UFF
RPRX icon

USA Financial Formulas’s Royalty Pharma RPRX Stock Holding History

USA Financial Formulas’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Buy
+4,439
New +$231K 0.05% 111
2025
Q4 		– Sell
-7,321
Closed -$258K – 464
2025
Q3 		$258K Buy
7,321
+6,428
+720% +$233K 0.05% 124
2025
Q2 		$32.2K Buy
+893
New +$29.6K 0.01% 210

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

USA Financial Formulas's RPRX Position: Q2 2026 in Review

USA Financial Formulas opened a new position in Royalty Pharma (RPRX) in Q2 2026: 4,439 shares worth $249K. The stake represents 0.05% of the portfolio and ranks #111 among its holdings. This is a return to the name: USA Financial Formulas previously reported a position in RPRX as recently as Q3 2025.

USA Financial Formulas first reported a position in RPRX in Q2 2025 and has held it in 3 quarters since. The position peaked at $258K in Q3 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • USA Financial Formulas held 4,439 shares of Royalty Pharma worth $249K as of Q2 2026.
  • Royalty Pharma was a new USA Financial Formulas position in Q2 2026.
  • Royalty Pharma made up 0.05% of USA Financial Formulas's portfolio in Q2 2026, its #111 holding.
  • USA Financial Formulas first reported a position in Royalty Pharma in Q2 2025 and has held it in 3 quarters since.
  • USA Financial Formulas's Royalty Pharma position peaked at $258K in Q3 2025.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.